Tag: rare genetic cardiomyopathies

BioMarin, DiNAQOR to develop gene therapies for rare genetic cardiomyopathies

pharmanewsdaily- May 4, 2020

BioMarin Pharmaceutical has signed a preclinical collaboration and license deal with Swiss gene therapy platform company DiNAQOR to develop novel gene therapies for the treatment ... Read More